THC, an intoxicating and illegal substance, is responsible for causing marijuana users to get “high.” Unlike THC, CBD is non-psychoactive because it does not act on the same pathways as THC. Thus, it is impossible to get “high” by smoking or ingesting CBD or CBD oil extracted from industrial hemp plants, as they only have minuscule traces of THC (<0.3%).
There are two main types of receptors in the ECS, CB1 and CB2. CB1 receptors are primarily located in the central nervous system and brains of mammals, and CB2 are generally found in the peripheral nervous system. There are two main cannabinoids mammals produce- 2AG and Anandamide (named after the Sanskrit term “Ananda,” which translates to “peace”).
Currently, the only official, FDA-approved use of CBD is as a component in a drug named Epidiolex, which will be used to treat severe forms of epilepsy in children and adults, and which will be, Carson hopes, available to patients by the end of the year. Carson says he developed an interest in CBD because parents of kids with epilepsy came to him having read about CBD’s potential benefits on the internet. “There’s lots of data now that I think really supports that CBD helps for epilepsy,” particularly in reducing the frequency of seizures, he says. Anecdotally, he noticed that the same parents reported another potential benefit associated with CBD: reduced anxiety. “I got the sense that some children did get benefits in terms of anxiety, and I think that’s where I wonder if for example CBD in coffee could potentially be helpful,” he says.
"Cannabinoids have been found to have antioxidant properties, unrelated to NMDA receptor antagonism. This new found property makes cannabinoids useful in the treatment and prophylaxis of wide variety of oxidation associated diseases, such as ischemic, age-related, inflammatory and autoimmune diseases. The cannabinoids are found to have particular application as neuroprotectants, for example in limiting neurological damage following ischemic insults, such as stroke and trauma, or in the treatment of neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease and HIV dementia.